aluminum hydroxide, magnesium hydroxide, drug combination has been researched along with nitroarginine in 2 studies
| Studies (aluminum hydroxide, magnesium hydroxide, drug combination) | Trials (aluminum hydroxide, magnesium hydroxide, drug combination) | Recent Studies (post-2010) (aluminum hydroxide, magnesium hydroxide, drug combination) | Studies (nitroarginine) | Trials (nitroarginine) | Recent Studies (post-2010) (nitroarginine) |
|---|---|---|---|---|---|
| 253 | 100 | 17 | 3,935 | 11 | 175 |
| Protein | Taxonomy | aluminum hydroxide, magnesium hydroxide, drug combination (IC50) | nitroarginine (IC50) |
|---|---|---|---|
| Nitric oxide synthase, endothelial | Bos taurus (cattle) | 1.2 | |
| Nitric oxide synthase, endothelial | Homo sapiens (human) | 0.38 | |
| Nitric oxide synthase, brain | Homo sapiens (human) | 1.265 | |
| Nitric oxide synthase, brain | Rattus norvegicus (Norway rat) | 4.12 | |
| Nitric oxide synthase, inducible | Mus musculus (house mouse) | 0.5 | |
| Nitric oxide synthase, inducible | Homo sapiens (human) | 6.2 | |
| Nitric oxide synthase, brain | Mus musculus (house mouse) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brzozowski, T; Konturek, SJ; Majka, J; Nauert, C; Slomiany, B; Szlachcic, A | 1 |
| Brzozowski, T; Konturek, SJ; Majka, J; Pytko-Polonczyk, J; Szlachcic, A | 1 |
2 other study(ies) available for aluminum hydroxide, magnesium hydroxide, drug combination and nitroarginine
| Article | Year |
|---|---|
Nitric oxide in gastroprotection by aluminium-containing antacids.
Topics: Aluminum Hydroxide; Animals; Antacids; Arginine; Dinoprostone; Drug Combinations; Ethanol; Gastric Mucosa; Hydrogen-Ion Concentration; Magnesium Hydroxide; Male; Nitric Oxide; Nitroarginine; Nitroglycerin; Prostaglandins F, Synthetic; Rats; Rats, Wistar; Regional Blood Flow | 1992 |
Implications of nitric oxide in the action of cytoprotective drugs on gastric mucosa.
Topics: Aluminum Hydroxide; Animals; Anti-Ulcer Agents; Arginine; Chalcone; Chalcones; Dose-Response Relationship, Drug; Drug Combinations; Ethanol; Gastric Mucosa; Magnesium Hydroxide; Male; Nitric Oxide; Nitroarginine; Organometallic Compounds; Prostaglandins F, Synthetic; Rats; Rats, Wistar; Regional Blood Flow; Sucralfate; Vasodilator Agents | 1993 |